While the bodys natural release of GLP-1 occurs briefly and only when food is present, these medications flood the system, leading to sustained metabolic effects
Beyond classical antioxidant signaling, GSH interfaces with additional pathways, including Hippo-Yes1 associated transcriptional regulator (YAP1) signaling to regulate GPX4 and SLC7A11 expression, 159,160 mechanistic target of rapamycin kinase (mTOR) signaling to influence GPX4 protein synthesis through cysteine metabolism, 161 and NF-B signaling to restrain inflammation-associated ROS production 162
If you prefer to take it orally though, look for S-acetyl L-glutathione
Understanding GIP and GLP-1 has revolutionized diabetes and obesity treatment, leading to FDA-approved medications that mimic their actions
Pace C, Tumino D, Russo M, Le Moli R, Naselli A, Borz G, et al
Sleep Med Clin